In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Michael Kors: Eau De Toilette is a lighter version of the designer's original namesake scent, created by softening the concentration of "rich, creamy florals," sensual woods and exotic incense in the signature juice, according to Estee Lauder. Positioned as "chic" and "seductive," Michael Kors Eau de Toilette will be housed in a redesigned bottle. "Whereas the original bottle featured a single distinctive 'M' to highlight Michael's 'signature,' the eau de toilette bottle features a chic linear pattern of miniature 'M's,'" the firm adds. The fragrance will debut in specialty and select fine department stores in September. A 1.7 oz bottle of the scent will retail for $55. The original Michael Kors fragrance debuted in 2000...

You may also be interested in...



Badgley Mischka Scent Struts Into High-End Doors This Summer

Fashion designer Badgley Mischka's eponymous scent for women will debut in high-end department stores in August, according to Riviera Concepts

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013985

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel